Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Mastering B-cell biomarker tracking in autoimmune therapy 7 days 10 hours 21 mins 30 secs SAVE YOUR SEAT!

Infographic: HRMS in DMPK

28 Nov 2019
General interest

As part of our Spotlight on HRMS, we carried out a survey to gain an insight into the trends, challenges and developments associated with the use of HRMS for DMPK studies. We would like to thank everyone who was able to share their thoughts by taking part in the survey – you can see the results below in our infographic.

HRMS in DMPK spotlight infographic_NM-01-min

< Back to – Spotlight: HRMS in DMPK

Top content

  • Novartis to acquire Avidity Biosciences in $12B deal to boost RNA therapeutics pipeline
  • How blockchain and AI are transforming data integrity in bioanalysis
  • AAPS PharmSci 360 2025: what can conference attendees look forward to?

Related tags

DMPK HRMS infographic QQQ Survey
Previous article Next article

Related articles

2 MAR 2018 EXPERT OPINION
Ask the Experts: Graeme Clark
10 JUN 2022 NEWS
New HRMS instruments, software and product enhancements unveiled by Waters
24 AUG 2016 JOURNAL ARTICLES
A workflow for absolute quantitation of large therapeutic proteins in biological samples at intact level using LC-HRMS
13 NOV 2019 GENERAL INTEREST
A new king of quantitation?
19 MAR 2012 DATA PROCESSING AND INTERPRETATION
High-resolution MS in drug discovery and development: current applications and future perspectives
3 JUL 2017 OLIGONUCLEOTIDES
Spotlight survey on oligonucleotides
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone